Ainos, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AIMD research report →
About the company
Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications.
- CEO
- Chun-Hsien Tsai
- IPO
- 2021
- Employees
- 44
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $8.47M
- P/E
- -0.81
- P/S
- 467.50
- P/B
- 1.98
- EV/EBITDA
- -2.30
- Div Yield
- 0.00%
- Gross Margin
- -26296.83%
- Op Margin
- -72393.48%
- Net Margin
- -76996.25%
- ROE
- -160.55%
- ROIC
- -63.81%
- Revenue
- $124.16K · 498.95%
- Net Income
- $-14,771,012 · 0.62%
- EPS
- $-3.46 · -121.79%
- Op Income
- $-13,990,408
- FCF YoY
- 20.25%
- 52W High
- $4.50
- 52W Low
- $1.26
- 50D MA
- $1.90
- 200D MA
- $2.20
- Beta
- 2.43
- Avg Volume
- 361.06K
Get TickerSpark's AI analysis on AIMD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 5, 26 | chiang yao-chung | buy | 3,500 |
| Jun 3, 26 | chiang yao-chung | buy | 2,000 |
| May 28, 26 | chiang yao-chung | buy | 250 |
| May 27, 26 | chiang yao-chung | buy | 2,000 |
| May 26, 26 | lee ting-chuan | sell | 109,988 |
| May 26, 26 | Taiwan Carbon Nano Technology Corp | sell | 41,000 |
| May 22, 26 | TSAI CHUN-JUNG | sell | 1,082 |
| May 26, 26 | TSAI CHUN-JUNG | sell | 27,718 |
| May 21, 26 | lee ting-chuan | sell | 9,000 |
| May 22, 26 | lee ting-chuan | sell | 9,302 |
Our AIMD coverage
Recent articles, reports, and earnings notes.
No research on AIMD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AIMD report →Similar companies
Peers in the same neighborhood.